CIK 0001710072
- Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821725586
- Phone
- +1 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $240,627
- in 2 filings, $39K under 10b5-1 plans
Net −$240,627. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-24 | Semigran Marc Chief Development Officer | Exercise or conversion 10b5-1 | +29,709 | $8.94 | $266K | 36,425 |
| 2024-12-24 | Semigran Marc Chief Development Officer | Sale 10b5-1 | −27,980 | $29.66 | $830K | 8,445 |
| 2024-12-24 | Semigran Marc Chief Development Officer | Sale 10b5-1 | −1,729 | $30.08 | $52K | 6,716 |
| 2024-12-24 | Semigran Marc Chief Development Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −29,709 | 270,291 | ||
| 2024-08-12 | Semigran Marc Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +138,750 | 138,750 | ||
| 2024-08-12 | Semigran Marc Chief Development Officer | Grant or award · Restricted Stock Units | +23,125 | 23,125 | ||
| 2023-08-17 | Semigran Marc Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +133,333 | 133,333 | ||
| 2022-12-30 | Semigran Marc Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 |
Page 1 of 1 · 8 trades